Friday, July 10, 2026

pharma · Scabies · Bioequivalence trial in healthy volunteers

Alphapharm

Alphapharm Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Scabies, Bioequivalence trial in healthy volunteers, moderate to severely inflamed candidiasis of the skin, Mild to mod

Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU HQ
1982 Founded
187 Employees
TGA registrant Type
Company details
Status
Public
HQ
Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
Founded
1982
Employees
187
Programs
30
Drugs
235
Patents
12
Clinical program

SymSF2

Approved · small molecule · Irritable Bowel Syndrome

SymSF2 for Irritable Bowel Syndrome is a Approved program (small_molecule) at Alphapharm Pty Ltd with 1 ClinicalTrials.gov record(s).

← All Alphapharm Pty Ltd projects Approved small molecule active

Internal code SymSF2

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Alphapharm Pty Ltd
Phase
Approved
Modality
small_molecule
Indication
Irritable Bowel Syndrome
Status
active
Trials
1